Featured White Papers
Technology Industry
Industry: Email Alert RSS FeedLipoScience of Raleigh has entered into a multi-year agreement with LabCorp of Burlington to offer its proprietary NMR LipoProfile® blood test, which uses nuclear magnetic resonance spectroscopy to measure the number of atherogenic LDL particles that build up in the arteries and cause heart disease
BT Catalyst, Sept-Oct, 2005
LipoScience of Raleigh has entered into a multi-year agreement with LabCorp of Burlington to offer its proprietary NMR LipoProfile[R] blood test, which uses nuclear magnetic resonance spectroscopy to measure the number of atherogenic LDL particles that build up in the arteries and cause heart disease.
LipoScience also has entered into a collaborative agreement with Mayo Clinic to validate the clinical utility of the LipoProfile test as a tool to measure cardiovascular risks.
COPYRIGHT 2005 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning